Overview

Tranexamic Acid Contribution in the Prevention of Perioperative Bleeding in Thoracic Surgery

Status:
Completed
Trial end date:
2019-10-02
Target enrollment:
0
Participant gender:
All
Summary
Bleeding after thoracic surgery is a major cause of perioperative hemodynamic instability and transfusion requirement, which can lead to a rise of morbidity, mortality and costs. The objective of this study is to evaluate the efficiency of tranexamic acid (TA) in the prevention of perioperative bleeding in thoracic hemorrhagic surgery.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University Tunis El Manar
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- over the age of 18 years old, programmed for potentially hemorrhagic thoracic surgery,
such as pulmonary resection for aspergilloma, pulmonary tuberculosis, pleural
decortication, lobectomy with parietectomy or redux.

Exclusion Criteria:

- Patients who have had a major complication of surgery other than bleeding requiring
revision within 24 hours or a complication related to anesthesia, and cases of
non-compliance with the anesthetic protocol are excluded.